GnRH for Luteal Support in IVF/ICSI/FET Cycles

Launched by UNIVERSITY REPRODUCTIVE ASSOCIATES · Feb 2, 2015

Keywords

ClinConnect Summary

This clinical trial is investigating whether adding a hormone called GnRH agonist can help improve the chances of a successful pregnancy for women undergoing in vitro fertilization (IVF) or frozen embryo transfers (FET). After an embryo is placed in the uterus, it needs the right hormonal support to implant and grow properly. While progesterone is commonly used to support the uterus, this study is looking at whether a one-time dose of GnRH agonist around the time of embryo transfer can further increase the chances of the embryo successfully implanting and leading to a live birth.

To participate in this trial, women must be under 40 years old and planning to undergo IVF, intracytoplasmic sperm injection (ICSI), or frozen embryo transfer. Unfortunately, those who are having their embryos transferred on the third day after fertilization are not eligible. If you join the study, you will receive the additional hormone treatment and be monitored closely to see how it affects your pregnancy journey. This research could provide valuable insights into improving fertility treatments for women like you.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • women undergoing IVF/ICSI or frozen embryo transfers (FET) that less than 40 years old.
• Exclusion Criteria:
• • day 3 transfers